|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0003 - 0.0004|
|52 Week Range||0.0003 - 0.0118|
|Beta (3Y Monthly)||-1.79|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Potomac, MD and Cheyenne, WY, May 13, 2019 -- via NEWMEDIAWIRE -- MJ Biotech, Inc. (f/k/a Michael James Enterprises, Inc.) (OTC: MJTV) announces that the Company has executed a.
Cheyenne, WY, Feb. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- (MJTV) MJ Biotech, Inc. (f/k/a Michael James Enterprises, Inc.) has a fully executed Letter of Intent to acquire a California based extraction laboratory producing HEMP based Cannabidiol (CBD) oil. This acquisition will provide MJ Biotech, Inc. the CBD oil required to produce its CBD infused Teas and Herbs. It will also allow MJ Biotech, Inc. to supply CBD oil to its current wholesale customer base.